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Microbiota in vitro modulated with
polyphenols shows decreased
colonization resistance against
Clostridioides difficile but can
neutralize cytotoxicity
Aleksander Mahnic1, Jennifer M. Auchtung2,3, Nataša Poklar Ulrih4, Robert A. Britton2 &
Maja Rupnik1,5 ✉
While the knowledge on gut microbiota - C. difficile interactions has improved over the years, the
understanding of the underlying mechanisms providing colonization resistance as well as preventative
measures against the infection remain incomplete. In this study the antibiotic clindamycin and
polyphenol extracts from pomegranate and blueberries were used individually and in combination to
modulate fecal microbial communities in minibioreactor arrays (MBRA). Modulated communities were
inoculated with C. difficile (ribotype 027). Subsequent 7-day periodical monitoring included evaluation
of C. difficile growth and activity of toxins TcdA and TcdB as well as analysis of MBRA bacterial
community structure (V3V4 16 S metagenomics). Polyphenols affected multiple commensal bacterial
groups and showed different synergistic and antagonistic effects in combination with clindamycin.
Exposure to either clindamycin or polyphenols led to the loss of colonization resistance against C.
difficile. The successful growth of C. difficile was most significantly correlated with the decrease in
Collinsella and Lachnospiraceae. Additionally, we demonstrated that Clostridium sporogenes decreased
the activity of both C. difficile toxins TcdA and TcdB. The feature was shown to be common among
distinct C. sporogenes strains and could potentially be applicable as a non-antibiotic agent for the
alleviation of C. difficile infection.
Clostridioides difficile infection (CDI) is a toxin mediated inflammation leading to diarrhoea and colitis, most
commonly occurring in the hospital environment. A disturbed balance in the gut microbiota, usually resulting
from antibiotic treatment, is needed for a successful colonization of the gastrointestinal tract (GIT) with C. difficile and the development of the infection1.
The gut microbiota provides colonization resistance against C. difficile via different mechanisms. Inhibition
of growth or spore germination can be achieved through biotransformation of primary bile acids2–4, as well as
pH reduction through organic acid production5,6. Other modes of action include the alteration of adhesion of C.
difficile to enterocytes7, co-aggregation of probiotic strain (e.g. Lactobacillus reuteri) with pathogen8 or simply
by competing for the adhesion sites. Selected fungal and bacterial strains were shown to decrease the activity
of C. difficile toxins TcdA and TcdB. In 1996, a serine protease was characterized from Saccharomyces boulardii
that inhibits toxin TcdA9, while more recently a protease with a similar effect was described in Bacillus clausii10.
Disruption of C. difficile quorum sensing, a mechanism crucial for the regulation of toxin synthesis, can also lead
to a decrease in toxin activity11,12.
Polyphenols are secondary plant metabolites found in abundance in food including different fruits, vegetables, seeds and herbs as well as in drinks such as coffee, tea and wine13. They are currently extensively researched
because of their anti-oxidant and anti-inflammatory properties14, but also exhibit beneficial effects on commensal
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bacterial groups while inhibiting the growth of potential pathogens, including C. difficile15,16. Both blueberry and
pomegranate extracts used in this study were previously reported to promote the growth of gut commensal bacteria and inhibit potential pathogens17–19 or modulate gut community towards beneficial outcomes20–22.
The aim of this study was to test if pre-exposure to polyphenols under in vitro conditions could affect microbial communities leading to the alleviation of the negative effects of antibiotics and subsequent improvement of
colonization resistance against C. difficile. The in vitro system (MBRA) used in this study was previously shown to
be suitable for studies concerning C. difficile – microbiota interactions23.

Results

Different polyphenols and clindamycin modulate the bacterial community in distinct ways. In
the set of 24 mini-bioreactors (MBRAs) seeded with a pooled fecal sample from two healthy subjects, 3 were
treated with clindamycin alone, 3 with a different polyphenol extract (PE, blueberry or pomegranate) and 3 with
each polyphenol in combination with clindamycin (see Materials and Methods, Fig. 5). Pomegranate PE was used
as a modulating factor at two concentrations, 100 mg/L and 400 mg/L. Dose dependant changes are shown in
the Supplementary Fig. S1, while only the results obtained with modulation at the concentration of 400 mg/L are
presented in the main article. Three non-treated bioreactors were used as a control.
After a five-day microbiota incubation (Fig. 1a, day 5), we observed an expected decrease in bacterial richness
in all treatments compared to the samples before the flow initiation (day 0; Fig. 1a). In subsequent time points the
number of OTUs remained stable until experiment termination (14 days; Fig. 1a). Compared to the samples taken
before the initiation of the flow, we observed a post-modulation increase in the relative abundance of different
representatives of Bacteroidetes and the reduction of the remaining four major phyla found in the gut (Fig. 1b).
Some key gut microbiota commensals could not be detected in the system after the modulation phase, including Bifidobacterium (OTU46 and OTU79), Akkermansia (OTU34) and multiple representatives of Clostridiales,
most prominently Faecalibacterium (OTU39). These were present in the initial samples before the initiation of
the flow at the average relative abundance of 0.8% (OTU46), 0.2% (Out79), 1.5% (OTU34) and 1.2% (OTU39).
A prior study using the MBRA system similarly reported the decrease or disappearance of certain Clostridiales
members including Faecalibacterium during the growth under similar continuous culture conditions, however in
this case Akkermansia successfully grew in the system24.
Microbial composition was most affected by modulation with clindamycin (AMOVA, p < 0.001). Clindamycin
exposed microbiota profiles grouped together, while communities treated with PE only grouped closer to the
untreated controls (Bray-Curtis dissimilarity dendrogram, Fig. 2a). However, only minor clindamycin-associated
changes were observed at the phylum level (Fig. 2a), most prominently the increase in Bacteroidetes/Firmicutes
ratio (p < 0.001). The most significant differentially represented OTUs are shown in Fig. 2b, while the complete
LEfSe analysis is presented in Supplementary Fig. S1.
The highest number of unique OTUs was detected in the untreated control. Clindamycin as well as PEs
decreased bacterial richness when applied alone (number of unique OTUs, p < 0.001; Fig. 2c). Interestingly, in
both combinations of clindamycin and PE (clindamycin + blueberry PE and clindamycin + pomegranate PE) the
number of detected OTUs decreased less compared to the bioreactors treated with clindamycin only (p < 0.001;
Fig. 2c). Treatment with the pomegranate PE led to an increase in community evenness both alone and in combination with clindamycin (Shannon evenness, p < 0.001; Fig. 2c). Treatment with blueberry PE on the other
hand further decreased community evenness when used in combination with clindamycin (Shannon evenness,
p < 0.001; Fig. 2c).
Blueberry and pomegranate PEs modulated the bacterial community in distinct ways (AMOVA, p < 0.001).
Several changes in microbial structure were however common to both PEs when compared to the control treatment. These included the increase in Eubacterium (OTU5) and Clostridium XIVa (OTU14) and decrease in
Collinsella (OTU43) and Clostridiales (OTU44). Other differentially represented OTUs were PE specific. Most
prominently, modulation with blueberry PE led to an increase in Clostridium XIVa (OTU3), Lachnospiraceae
(OTU7), Flavonifractor (OTU12), Eggerthella (OTU49) and unclassified Firmicutes (OTU55). Modulation with
pomegranate PE led to an increase in Ruminococcaceae (OTU27) and Clostridium IV (OTU67) (Fig. 1b). The
complete LEfSe analysis is shown in Supplementary Fig. S1.
The treatment of microbiota with PEs and clindamycin in combination resulted in specific patterns indicating
antagonistic and synergistic effects between the two. Most noteworthy we found bacterial groups which were
decreased after the exposure to clindamycin alone but were unaffected when PEs were used in combination
with clindamycin. Among these, blueberry PE minimized the adverse effect of clindamycin on Blautia (OTU16)
and Clostridium XVIII (OTU18). Pomegranate PE minimized the adverse effect of clindamycin on Bacteroides
(OTU10), Flavonifractor (OTU12) and Lachnospiraceae (OTU19). Both blueberry and pomegranate PEs alleviated the adverse effect of clindamycin on Clostridium XIVa (OTU9). On the other hand, we also observed a
synergistic effect of PEs and clindamycin. A combination of clindamycin and either PE resulted in a decrease in
Anaerotruncus (OTU100) which was unaffected when either PE or clindamycin were used individually (Fig. 2b).
Pomegranate effects at the lower PE concentration (100 mg/L) were in concordance with results observed at PE
concentration of 400 mg/L (Supplementary Fig. S1).
Colonization resistance to C. difficile decreased after polyphenol exposure. After the modulation period we performed a 2 day wash out period in order to allow the communities to stabilize and to wash the
modulation factors (PEs and clindamycin) out of the system. From this point on the bioreactors were supplied
with medium without modulation factors. Subsequently, on day 7 we inoculated all bioreactors with C. difficile
vegetative cells at the final concentration of approximately 105 CFU/mL. The growth and cytotoxicity of C. difficile
were periodically measured for the next 7 days.
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Figure 1. Bioreactors supported the growth of stable communities. a Number of unique OTUs observed
throughout the experiment duration. Color indicates treatment with polyphenol extract (PE), dotted line
indicates treatments where clindamycin was used as modulating factor. Letters on the top indicate experimental
phase: M – modulation period, W – wash-out period and CD – post C. difficile inoculation period. b Box
presentation of the relative abundance of bacterial phyla shown for the samples before the flow initiation (before
flow, black) and for all remaining time points (after flow initiation, grey).
As expected, control (untreated) microbial communities exhibited colonization resistance against C. difficile
while in communities that were treated with clindamycin during the modulation period C. difficile grew successfully (Fig. 3a). We hypothesised that PEs will modulate microbiota towards an increased resilience against
clindamycin induced changes resulting in colonization resistance in bioreactors exposed to the combination of
PE and clindamycin. Contrary to our expectations, C. difficile grew successfully in all treatments exposed to PEs
(alone and in combination with clindamycin) (Fig. 3a).
Several community characteristics correlated significantly with C. difficile growth (Fig. 3b). The number of
unique observed OTUs (community richness) was negatively correlated with C. difficile concentration (Pearson’s
r = −0.49, p-value <0.001). The two OTUs most significantly negatively correlated with C. difficile growth
were Collinsella (OTU43; Pearson’s r = −0.56, adjusted p-value <0.001) and Lachnospiraceae (OTU7; Pearson’s
r = −0.53, adjusted p-value <0.001) (Fig. 3b). The OTU most significantly positively correlated with C. difficile growth was Eubacterium (OTU5; Pearson’s r = 0.41, adjusted p-value = 0.035) (Fig. 3b). No correlation was
observed with overall bacterial diversity (Shannon index). Detailed presentation of correlation patterns is available in Supplementary Fig. S2. Additionally we report that neither PE used in this study exhibited any direct effect
on C. difficile growth or cytotoxicity at concentrations lower than 2000 mg/L (Supplementary Fig. S3).

A subset of the PE modulated microbial communities reduced cytotoxicity but did not affect
C. difficile growth. Cytotoxicity of bioreactor supernatants was measured by performing tests on two cell
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Figure 2. Polyphenols and clindamycin modulated microbiota in distinct ways. a Dendrogram presentation
of Bray-Curtis dissimilarities with the bar-plot presentation of the relative abundance of 3 dominant bacterial
phyla. Sample names are colored according to polyphenol extract (PE), that was used during the modulation
phase. Green indicates control treatment, blue exposure to blueberry PE and orange exposure to pomegranate
PE. Abbreviation “Cli” indicates exposure to clindamycin. b LEfSE analysis showing the comparison between
communities exposed to either PE, clindamycin or combination of both compared to the control treatment.
LDA values are presented as heat-plot with red indicating a decrease of specific OTU while blue an increase.
Letter before OTU taxonomy indicates taxonomic level: g - genus, f - family, o - order, p - phylum. c Box
presentation of the number of unique OTUs and Shannon evenness according to the treatment.

lines, HT-29 (more sensitive to TcdA) and Vero (more sensitive to TcdB). Measurements from both cell lines were
correlated although the values were significantly lower for the HT-29 cell line (Fig. 3c). Two days after C. difficile
inoculation we additionally quantified TcdA and TcdB separately with an ELISA assay and the results are in congruence with the cytotoxicity assays (Supplementary Figure S4).
The activity of toxins correlated with C. difficile growth (Pearson’s r = 0.33 and 0.27, p-value = 0.001 and
0.009 for HT-29 and Vero, respectively). The exception was the bioreactor in which the microbiota was exposed
to pomegranate PE in combination with clindamycin (Fig. 3c). Here, the relative cytotoxicity units per C. difficile
CFU (RCU/C. difficile CFU) were significantly lower in comparison to other treatments, which were exposed
to clindamycin during the modulation phase (p < 0.001). This indicated good C. difficile growth but a decrease
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Figure 3. C. difficile growth- and cytotoxicity-associated bacterial community characteristics. Timeline of C.
difficile growth (log10 CFU/mL) (a) and cytotoxicity (log10 Relative Cytotoxicity Units (RCU)/C. difficile CFU)
shown for cell lines HT-29 and Vero, separately (c). Dotted line indicates exposure to clindamycin during the
modulation phase. b,d Pearson analysis of OTU correlation with C. difficile growth (b) and cytotoxicity (d). Red
color indicates negative correlation with either C. difficile growth or cytotoxicity while blue indicates a positive
correlation.
in cytotoxicity. Using the Pearson correlation test we identified OTUs which were correlated with the reduction
in cytotoxicity (Fig. 3d). We found that among the OTUs listed in Fig. 3d, an increase in either Clostridium
(OTU22) or Blautia (OTU16) corresponded to bioreactor specific reduction in cytotoxicity to the largest extent
(Supplementary Figure S5).

C. sporogenes decreases the activity of toxins TcdA and TcdB but does not impact C. difficile
growth. From the bioreactor content, we successfully isolated four bacterial strains which corresponded to

the OTUs correlated with the decrease in cytotoxicity. Using 16 S rRNA gene sequencing (Sanger method) we
identified these to be two distinct Clostridium sporogenes strains (MBRA strain 1 and 2), Clostridium oroticum
and Blautia sp. strain, corresponding to OTUs Clostridium (OTU22), a Clostridium XIVa (OTU33) and a Blautia
(OTU16), respectively.
Isolated strains were co-cultured with C. difficile to test their impact on C. difficile growth and cytotoxicity. The
C. sporogenes strain (MBRA strain 1) was able to decrease the activity of toxins per C. difficile CFU (p < 0.001)
while no impact on C. difficile growth was observed. No such effect was observed with Blautia sp. and C. oroticum
(Fig. 4). We additionally tested 7 distinct environmental C. sporogenes strains and observed the inhibitory effect
towards both C. difficile toxins TcdA and TcdB in all instances (Supplementary Figure S6).

Discussion

In the present study we have shown that an in vitro modulation of human fecal microbial communities in MBRAs
can lead to different C. difficile colonization-associated outcomes in a replicable manner. Contrary to our expectations, modulation with PEs decreased colonization resistance against C. difficile. Growth of C. difficile and the
activity of toxins TcdA and TcdB were correlated with specific bacterial groups in a complex community. Further,
we have demonstrated a direct inhibitory effect of C. sporogenes on both C. difficile toxins TcdA and TcdB.
Blueberry and pomegranate PE modulated microbiota in a distinct manner, which was only partially in concordance with previous published data18,21. Discrepancies can result from different polyphenol extract composition and concentration as well as different microbial community and bioreactor characteristics, making these
studies difficult to compare. Contrary to our expectations both polyphenols modulated the microbial community
towards the loss of colonization resistance against C. difficile. The direct inhibitory effects of polyphenols on C.
difficile growth were previously reported16. However, no previous studies concerning C. difficile colonization in
polyphenol modulated microbial communities (in vivo or in vitro) could be found. Unrelated to C. difficile, studies predominantly reported beneficial effects of polyphenols on commensal microbiota13. However, our findings
suggest that polyphenols can have an adverse effect on some commensal bacterial groups, most importantly
different representatives from Clostridiales.
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Figure 4. C. difficile cytotoxicity per CFU after co-culture with different bacterial strains. C. sporogenes, C.
oroticum and Blautia sp. strains were isolated from MBRA content while Clostridium scindens and E. coli were
used as controls. Strains were tested in co-culture with C. difficile. Graph presents average measurements of
relative cytotoxicity units (Vero cells) per C. difficile CFU ± SD (n = 3).

Figure 5. Schematic presentation of the experiment design. a Time progression of the experiment with the
events noted on the timeline. Table below timeline shows at which time points were different tests performed.
b The setup of 24 bioreactors (8 unique treatments each done in triplicate) according to the modulation factors
used.

An important aspect is the concentration of supplemented polyphenols and the mode of delivery.
Concentrations used in our study were calculated as an approximation to a daily consumption of one tea spoon
of polyphenol extract in relation to an average lumen of an adult gastrointestinal tract. Similar concentrations
were also used by others in the past25–27. Also we supplied polyphenol extracts at a low dose continuously in the
media as oppose to the ingestion of the daily dose at once. Overall, it is difficult to simulate daily consumed doses
of polyphenol extract under laboratory conditions. Further concentration and application dependent effects of
polyphenol extract as well as in vivo studies are therefore required to assure safe implementation of polyphenols
in consumable products.
Both polyphenols showed synergistic and antagonistic effects with clindamycin towards different bacterial
groups, mainly representatives from Clostridiales. Antagonistic effects are rarely reported28–30. Synergistic effects
are, on the other hand, more common and interesting because of the potential to decrease antibiotic doses during
infection treatment31–33. These effects are commonly investigated on common pathogens; however, they should
also be investigated on commensal bacterial groups. Adverse synergistic effects affecting commensal clostridia are
interesting for future research because of their potential to stimulate the development of dysbiosis in susceptible
subjects.
The development of microbial communities was bioreactor-specific, diverging also among replicates of the
same treatment, as previously reported24. In the referenced study the authors discussed development and stability of communities in MBRA as well as possible reasons for differences among replicates into great detail.
Nevertheless, C. difficile colonization- and cytotoxicity-associated outcomes were in our case treatment specific
and bacterial community associations were highly significant.
Representatives of Lachnospiraceae and Collinsella were most prominently associated with the inhibition of
C. difficile growth, both in concordance with previously reported data. Members of Lachnospiraceae were highlighted as protective against development of CDI in patients after allogeneic hematopoietic stem cell transplantation34 and were able to alleviate CDI-associated symptoms in germfree mice35. Collinsella was previously reported
to be decreased in CDI patients36. Also, both Lachnospiraceae and Collinsella are known to participate in the
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biotransformation of bile acids37–39. Despite this, the exact mechanism responsible for the observed associations
with C. difficile growth in our in vitro system could not be clarified with the available data.
Previously reported bacteria and fungi mediated suppression of C. difficile toxins9,10,40,41 does not include C.
sporogenes. Suppression of toxin activity mediated by a heat sensitive secondary metabolite has been observed for
Lactobacillus delbrueckii40, L. lactis41 and Bacillus clausii10. A serine protease producing Saccharomyces boulardii9
was shown (as a sole probiotic strain as well as in combination with bacterial probiotic strains) to be effective at
the prevention of primary CDI42. However, probiotics with fungi are not recommended for pregnant women and
immune-compromised patients because of an elevated risk of fungemia43. Commensal bacterial strains such as
C. sporogenes could in such cases present a safer alternative. We have not further examined the molecular basis
of the observed activity.
In conclusion, exposure of microbiota to blueberry and pomegranate PEs led to a decrease of colonization
resistance against C. difficile. Future in vivo studies are required; however, our results indicate that polyphenols are
strong microbiota modulators that also exhibit synergistic and antagonistic effects with clindamycin and should
therefore be further investigated for a safer use. In spite of this decrease in colonization resistance, pomegranate
PEs in some instances inhibited C. difficile toxin activity, likely by promoting expansion of C. sporogenes. C.
sporogenes was further shown to neutralize the cytotoxicity of the main C. difficile toxins TcdA and TcdB.

Materials and methods

Preparation of polyphenolic extracts.

Ripe blueberries (Vaccinium myrtillus L.) were sampled in
Slovenia and stored for 7 days at −20 °C prior to the beginning of the extraction process. The method has been
already described44 and is briefly presented here. Frozen samples (50 g) were homogenized in 150 mL of ice-cold
deoxygenated methanol, previously flushed for a few minutes by nitrogen. Homogenate was extracted for 3 h by
shaking (Shaker EV403, Tehtnica, Zelezniki, Slovenia) in the dark at room temperature. The extract was centrifuged and the supernatant was stored at − 20 °C. The sediment was extracted again in 100 mL of deoxygenated
methanol for 2 h in the dark at room temperature and the suspension was centrifuged. To completely remove
the methanol after polyphenol extraction, the sample was first dried in a Speed-Vac, then frozen at −80 °C and
lyophilized. With this procedure we completely remove the organic solvents. Finally, both supernatants were
pooled, flushed with nitrogen for a few minutes and then stored at − 20 °C until analyzed44.
Pomegranate (Punica granatum L.) fruits were harvested in the normal ripening period in Istria (Marasi). The
pomegranate seeds or arils were separated from the peel and mesocarp. Different parts of pomegranate (mesocarp, squeezed juice from arils and peel) were lyophilized and crushed to powder45. Here we used the ethanol
extracts from dry peels prepared by extracting lyophilized powdered peels in 70% ethanol for four hours. The
extracts were centrifuged and dried using rotary evaporation and lyophilization. Extracts were kept at −20 °C
until needed. For experiments all extracts were dissolved in distilled sterile water to avoid the additional effect of
alcohol on microbiota

Minibioreactor arrays (MBRAs) experiment setup.

The MBRA setup design and medium preparation used in this study is described in great detail in Auchtung et al.46. Importantly, MBRAs allow a simultaneous running of 24 independent continuous flow bioreactors. Bioreactors have an internal volume of 25 mL
and working volume of 15 mL. The MBRAs were set in an anaerobic chamber under anaerobic atmosphere (5%
CO2–5% H2–90% N2) at a constant temperature of 37 °C. The media was continuously replenished, and waste
was removed at a flow rate of 1.875 mL/h. MBRA system is stationed on the magnetic stir plate allowing for a
constant stirring of the bioreactor slurry during operation.
Bioreactors were inoculated with a pooled stool sample from two subjects. The two fecal samples were randomly selected from a bank of samples of anonymous donors between the ages of 18–65 who self-identified as
healthy and had not consumed antibiotics in the previous 6 months; the pool of anonymous donors included
samples from male and female donors. Stool sample collection and preparation before inoculation is described
in Auchtung et al.24. Stool sample collection was reviewed and approved by the Institutional Review Board from
Michigan State University and all the study procedures were carried out in accordance with relevant guidelines.
All individuals donating samples provided informed consent prior to donation.
After inoculation the communities were left to stabilize in MBRAs for 24 h without flow (Fig. 5a). Prior publication using the same system determined that the period of 24 h was sufficient for stabilization based on the
changes in microbial diversity24. After the flow initiation, bioreactors were supplied with different combinations
of modulating factors added into the BDM medium46 resulting in 8 unique treatments, each done in a triplicate
(Fig. 5b). Reactor medium was buffered with phosphate buffer and 5% CO2/0.2% bicarbonate buffering system.
Previous experiments have demonstrated that this buffering system is sufficient to buffer from pH changes due
to metabolism of 10X excess of complex carbohydrates compared to what was used in the medium. Antibiotic
clindamycin and two polyphenolic extracts (PE; blueberry and pomegranate) were used as modulating factors.
Physico-chemical transformation of media and modulating factors during the supplementation of bioreactors
was not investigated. Clindamycin was used at a final concentration of 250 mg/L, blueberry polyphenolic extract
was used at a final concentration of 400 mg/L and pomegranate polyphenolic extract was used at two concentrations, 100 mg/L and 400 mg/L. Solution of polyphenolic extracts was prepared in dH2O. The modulation with
PEs was initiated simultaneously with the flow for the next 5 days, while the modulation with clindamycin was
initiated 1 day later for the next 4 days (Fig. 5a).
After the modulation period, MBRAs were supplied with BDM medium for 2 days (wash out period) in
order to stabilize communities and wash out the modulating factors from bioreactor content. Subsequently we
inoculated all bioreactors with the C. difficile culture (CD2015; ribotype 027) at the final concentration of approximately 105 vegetative cells/mL. For the next 7 days each bioreactor was periodically sampled. We tested the C.
difficile growth, sporulation and cytotoxicity as well as bacterial community composition (Fig. 5a).
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We did not measure the basal concentrations of polyphenols in the donor’s feces or measure the
polyphenols-derived metabolites produced in the bioreactors.

Measurement of C. difficile cell concentration. Total number of colony forming units (CFU) was deter-

mined by plating serial dilutions of bioreactor content onto the C. difficile selective media TCCFA with 50 μg/ml
rifampicin and 20 μg/ml erythromycin.

Cytotoxicity test for semi-quantitative measurement of the activity of C. difficile toxins TcdA
and TcdB. A cytotoxicity test was performed on HT-29 cells (more sensitive to TcdA) and Vero cells (more

sensitive to TcdB). Frozen culture (−80 °C) of either cell line HT-29 or Vero was thawed in a water bath (37 °C
for 5 min). The content (1 mL) was combined with 5 mL of fresh medium (DMEM (Gibco) + 10% fetal bovine
serum (FBS) at 37 °C) in the cell culture flask (25 cm2). Cell culture was incubated at 5% CO2 and 37 °C. After the
formation of a monolayer, cells were trypsinized and transferred to 75 cm2 flasks with 9 mL of DMEM (Gibco) +
10% FBS and incubated at 5% CO2 and 37 °C. Before preparing mature cells for the assay, cells were centrifuged
(5000 rpm for 5 min), counted to determine concentration and diluted with fresh DMEM (Gibco) + 10% FBS to
the final concentration of 5 × 104 cells /mL. The suspension was then aliquoted in the 96-well plate (100 μL per
well) and incubated for 24 h at 5% CO2 and 37 °C.
Supernatants for the assay were prepared by first centrifuging the bioreactor content (20000 rpm for 20 min)
and a subsequent filtration of the supernatant (0.2 μM filter, PES membrane). The five-fold serial dilutions of
supernatant were added to the formed cell monolayer and incubated 24 h at 5% CO2 and 37 °C.
The scoring of the cytotoxic effect was determined as follows: 1) no cell rounding effect (0 points), 2) from
approximately 30% to 70% of cells were rounded (0.5 points) and 3) more than 70% of cells were rounded (1
point). Each score was subsequently used as an exponent to the base 10 to obtain relative cytotoxicity units
(RCUs).

Detection of C. difficile toxins TcdA and TcdB with commercial test. Each toxin separately was
additionally quantified with the TGC-E002–1 kit (tgcBIOMICS, Germany) according to the recommended protocol. The concentration of each toxin was determined based on a standard dilution curve, obtained with purified
toxins TcdA and TcdB provided in the kit.
16S rRNA gene sequencing of MBRA bacterial communities.

MBRA content samples (1 mL) were
centrifuged at 14000 rpm for 1 min to obtain a pellet, which was stored at −80 °C until further use. Total DNA
was extracted with QIAamp DNA Mini kit (QIAGEN) using a modified protocol. Pellets were re-suspended using
360 μL of buffer ATL and homogenized in MagnaLyser (Roche) at 7000 rpm for 70 s. Next, 40 μL of proteinase K
was added followed by an incubation at 55 °C (1 h). In the next step 200 μL of buffer AL was added followed by
an incubation at 70 °C (30 min). After the addition of 200 μL of 96–100% ethanol the content was transferred into
column tubes and the subsequent steps followed the protocol provided in QIAamp DNA Mini kit. Extracted DNA
was stored at −80 °C until further use.
Bacterial community structure was determined by sequencing the V3V4 variable region of the 16 S
rRNA gene. Libraries were prepared according to the 16 S Metagenomic Sequencing Library Preparation
(Illumina) protocol using the primer pair Bakt_341F (5′-CCTACGGGNGGCWGCAG-3′) – Bakt_805R
(5′-GACTACHVGGGTATCTAATCC-3′) (approximately 460 bp fragment47). Sequencing was performed on the
Illumina MiSeq platform (paired-end sequencing, 2 × 300 bp).

Sequence data analysis and statistics. Quality filtering was performed using mothur (v.1.36.1)48 follow-

ing the protocol recommended in Kozich et al.49. Silva reference base (Release 123) was used for the alignment.
Chimeras were identified using mothur implemented UCHIME algorithm. Taxonomy was inferred using the
RDP training set (v.12) provided by mothur implementing 0.80 bootstrap value.
We obtained a total of 7576427 reads (min: 14453, max: 81825, average per sample: 39460.56). We removed
reads which were present at the overall abundance lower than 0.01% and rarefied the number of reads to 14000
reads per sample using random sampling implemented in mothur.
Downstream analysis was performed in mothur (calculation of alpha diversity indices (Shannon index,
Shannon evenness index), beta diversity indices (Bray-Curtis and AMOVA testing) and population-level analysis
(linear discriminant analysis effect size, LEfSe)50. Remaining statistics were performed in R environment (version
3.1.3)51 using packages ‘vegan’52. All graphical presentations were made in R environment with package ‘ggplot2′53
except Fig. 5, which was created in PowerPoint (Microsoft).

Testing the effect of different strains on C. difficile growth and cytotoxicity.

Three C. difficile
strains were used in testing, all belonging to the ribotype 027. These included C. difficile strain used in the MBRA
experiment (CD2015) and two strains from NLZOH collection (ZZV12-4777 and ZZV14-5907). C. difficile
strains were tested in combination with four strains that were successfully isolated from bioreactor contents. These
included two C. sporogenes strains, C. oroticum and Blautia sp. strains. Identification was performed with Sanger
sequencing of the entire 16 S rRNA gene. Sanger sequencing was performed using the universal bacterial primer
pair 27fevb (5′-GAGAGTTTGATCCTGGCTCAG-3′) – 1495revb (5′-CTACGGCTACCTTGTTACGA-3′) on
the Applied Biosystems 3500 Series Genetic Analyzer (Thermo Fisher Scientific) according to the previously
published protocol54. Sequences were subsequently compared to the MiSeq reads. With high certainty we were
able to show that these strains correspond to Clostridium (OTU22), a Clostridium XIVa (OTU33) and a Blautia
(OTU16), respectively. Growth curves for all strains tested were determined by absorbance measurement at OD
600 nm.
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Co-culturing assay was performed in 6-well plates with 5 mL working volume. The overnight culture (24 h) of
the in vitro C. difficile strain and the bacterial strain under investigation (C. sporogenes, C. oroticum and Blautia
sp.) (50 μL) was added to 5 mL of anaerobic Wilkins-Chalgren Anaerobe Broth (WCAB). After 24 h incubation
at 37 °C in anaerobic atmosphere we sampled 1 mL. Total CFU count was performed by plating serial dilutions
on CHROMID C. difficile (BioMerieux). Cytotoxicity assay was performed as described above but only on cell
line Vero.
Three C. difficile strains and nine C. sporogenes strains were additionally tested for the effect of cell-free C.
sporogenes supernatants on C. difficile toxins TcdA and TcdB. Two C. sporogenes strains were isolated from bioreactor slurry (MBRA strain 1 and 2) while seven were obtained from NLZOH collection. C. difficile strains were
cultured overnight (24 h). C. sporogenes strains were sampled after 48 h cultivation. Samples were filter sterilized
(PES membrane, 0.2 μM, Sarstedt). Combinations of C. difficile/C. sporogenes supernatants (1:1 volume ratio)
were incubated for 12 h at 37 °C in anaerobic conditions with shaking. TcdA and TcdB toxin activities were quantitatively measured with ELISA test (TGC-E002-1, tgcBIOMICS).

Data availability

The datasets supporting the conclusions of this article are available in the form of combined paired
end reads (contigs) on the Metagenomics RAST (MG-RAST) database server (http://metagenomics.
anl.gov/) under the project access number mgp90214 (https://w w w.mg-rast.org/mgmain.
html?mgpage=project&project=mgp90214).
Received: 13 January 2020; Accepted: 21 April 2020;
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